Moreover, KMT2D is critical for mediating the survival of activation-induced naïve CD8+T cells (21), and KMT2D variants in colorectal cancer have been linked to increased CD8+T cells (22), more immune cell infiltration, and enrichment of immune-related genes and pathways (23). Here, CD8A is linked to colorectal cancer.